Experimental Drugs Without FDA Approval Are Now Legal in Montana - VICE
Montana has legalized experimental drugs without FDA approval, creating a regulatory conflict with federal law. This may affect pharmaceutical manufacturers operating in or distributing to Montana, particularly regarding cGMP compliance and drug approval requirements.
Aforeworn detected this change in the Pharmaceutical Manufacturing (FDA/DEA) space on July 28, 2026 and published this briefing so affected operators are forewarned rather than caught off guard. It is rated High urgency. Branded drug makers, generic/ANDA manufacturers, API & contract manufacturers, compounding outsourcing facilities (503B) with operations or distribution in Montana. should confirm how it applies to their specific situation before acting. There is a time constraint attached: Immediately, as the law is already in effect.. Acting after that point can mean penalties, a lapsed licence, or lost eligibility — exactly the kind of surprise Aforeworn exists to prevent. Aforeworn monitors Pharmaceutical Manufacturing (FDA/DEA) continuously and turns every detected change into a plain-English briefing like this one, so you always know first. Forewarned is forearmed.
What changed
Montana law now permits the use and distribution of experimental drugs not approved by the FDA, conflicting with federal requirements for FDA approval and cGMP compliance.
Who it affects
Branded drug makers, generic/ANDA manufacturers, API & contract manufacturers, compounding outsourcing facilities (503B) with operations or distribution in Montana.
What you must do
Review legal exposure and update compliance policies to address potential conflicts between state and federal law. Consult legal counsel to determine if operations in Montana need adjustment.
Deadline
Immediately, as the law is already in effect.
Never miss a change like this again
Aforeworn watches Pharmaceutical Manufacturing (FDA/DEA) around the clock and alerts you the moment a rule moves — with a plain-English brief on what to do.
Start your free trialRelated changes in Pharmaceutical Manufacturing (FDA/DEA)
- Justice Department eases restrictions on some marijuana products - CBS News
- Feds give 2-year approval to Florida’s Canadian prescription drug importation plan - Florida Politics
- GLP‑1 Compliance: FDA Targets Telehealth Marketing in 30 New Warning Letters - JD Supra
- Court of Appeals Affirms Judgment that Struck Down Rule Mandating Price Disclosure in Pharmaceutical Ads - Holland & Knight
- Virginia Prepares to Accept Applications for a Single Medical Cannabis License for Health Service Area 1, Which Includes the Shenandoah Valley - Foley Hoag